Transcriptomic changes in pancreatic islets, adipose and liver after Roux-en-Y gastric bypass in a diet-induced obese rat model.


Journal

Peptides
ISSN: 1873-5169
Titre abrégé: Peptides
Pays: United States
ID NLM: 8008690

Informations de publication

Date de publication:
02 2021
Historique:
received: 27 08 2020
revised: 28 10 2020
accepted: 21 11 2020
pubmed: 1 12 2020
medline: 15 12 2021
entrez: 30 11 2020
Statut: ppublish

Résumé

Roux-en-Y gastric bypass (RYGB) is the most efficient intervention in morbid obesity and promotes metabolic improvements in several peripheral tissues. However, the underlying molecular mechanisms are still poorly understood. To further understand the effects of RYGB on peripheral tissues transcriptomes, we determined transcriptome signatures in pancreatic islets, adipose and liver tissue from diet-induced obese (DIO) rats model following RYGB. Whereas RYGB led to discrete gene expression changes in pancreatic islets, substantial transcriptome changes were observed in metabolic and immune signaling pathways in adipose tissue and the liver, indicating major gene adaptive responses in fat-storing tissues. Compared to RYGB DIO rats, peripheral tissue transcriptome signatures were markedly different in caloric restricted weight matching DIO rats, implying that caloric restriction paradigms do not reflect transcriptomic regulations of RYGB induced weight loss. The present gene expression study may serve as a basis for further investigations into molecular regulatory effects in peripheral tissues following RYGB-induced weight loss.

Identifiants

pubmed: 33253774
pii: S0196-9781(20)30216-3
doi: 10.1016/j.peptides.2020.170467
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

170467

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Auteurs

Chen Zhang (C)

Gubra ApS, Hørsholm, Denmark.

Lise Christine Biehl Rudkjær (LC)

Gubra ApS, Hørsholm, Denmark.

Marisa Fernández Cachón (MF)

Sanofi-Aventis Deutschland GmbH, Frankfurt am Main, Germany.

Mechthilde Falkenhahn (M)

Sanofi-Aventis Deutschland GmbH, Frankfurt am Main, Germany.

Stefan Theis (S)

Sanofi-Aventis Deutschland GmbH, Frankfurt am Main, Germany.

Thorsten Schmidt (T)

Sanofi-Aventis Deutschland GmbH, Frankfurt am Main, Germany.

Niels Vrang (N)

Gubra ApS, Hørsholm, Denmark.

Jacob Jelsing (J)

Gubra ApS, Hørsholm, Denmark.

Kristoffer Rigbolt (K)

Gubra ApS, Hørsholm, Denmark. Electronic address: kri@gubra.dk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH